Anti-cytokeratin CAM 5.2 does not act as a surrogate of the cytokeratin 8/18 monoclonal antibody. Comment on: "Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma", in J Cutan Pathol 2009; 36: 543.
Chen
Jih-Tseng
JT
Hsu
Jeng-Dong
JD
Yao
Chung-Chin
CC
Han
Lih-Wen
LW
Han
Chih-Ping
CP
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods / Q000592:standards*; D053538:Keratin-18 / Q000096:biosynthesis*; D053533:Keratin-8 / Q000096:biosynthesis*; D007633:Keratins / Q000096:biosynthesis*; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000378:metabolism
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D014408:Biomarkers, Tumor; C400901:CAM 5.2 antigen; D053538:Keratin-18; D053533:Keratin-8; D007633:Keratins